Revolutionary Snake Antivenom Created from Insights of a Man Bitten Over 200 Times

Scientists are making strides toward a universal antivenom, largely thanks to a man named Tim Friede. He spent nearly two decades injecting himself with snake venom, resulting in unique antibodies in his blood. These antibodies might protect against bites from various snake species, potentially revolutionizing how we treat snakebites globally.

Each year, snakebites lead to about 14,000 deaths and create disabilities for many more. Traditional antivenoms are tailored to specific snake species, making them less effective in a global context. That’s where Friede’s journey comes in. He endured over 200 snake bites and more than 700 venom injections from highly venomous snakes, including cobras and mambas, initially to build personal immunity.

Dr. Jacob Glanville, a biotech CEO, recognized the significance of Friede’s unique blood and sought samples for research. The goal is to harness Friede’s broadly neutralizing antibodies that can target common elements across different snake venoms. This could mean protection from a wide variety of snake species with one solution.

Recent studies highlighted in the journal Cell show promising results. Researchers identified two powerful antibodies from Friede’s blood that could protect against venoms from 13 out of 19 snake species tested. The potential breadth of protection is considered groundbreaking.

Experts believe that progress can continue. Prof. Peter Kwong, involved in the research, stated that within the next decade or so, we might have effective treatments for each type of snake venom. This research’s novelty lies in its approach to understanding snake venoms in a broader context, as opposed to focusing solely on individual species.

The journey isn’t without its challenges. Prof. Nick Casewell, head of the Centre for Snakebite Research at the Liverpool School of Tropical Medicine, noted that while the findings are groundbreaking, further research and testing are needed before any treatment can be safely administered to humans.

For Friede, the journey isn’t just personal. He aims to contribute positively to humanity. “I’m doing something good,” he says, proud of the potential impact of his sacrifice. The road ahead may be long, but the hope for a universal antivenom is sparking excitement in the medical community.

Source link